POST Online Media Lite Edition


Indonesia approves emergency use of Pfizer's COVID-19 vaccine

Christian Fernsby |
Indonesia's Food and Drug Authority (BPOM) has issued an emergency use authorization (EUA) for Pfizer's COVID-19 vaccine amid a spike in cases as the more contagious Delta variant has entered the country, an official said on Thursday.

Article continues below

"BPOM has issued the EUA for the vaccine produced by Pfizer and BioNTech with the mRNA platform," BPOM's head Penny K. Lukito told a virtual press conference.

Indonesia has an agreement to procure 50 million doses of Pfizer vaccine throughout 2021.

Indonesia has so far given EUA approvals to five COVID-19 vaccine producers, namely Sinovac, Sinopharm, Pfizer, Moderna and AstraZeneca.

Indonesia recorded on Thursday 56,757 new COVID-19 cases, the highest since the pandemic hit the country for the first time in March last year, bringing the total tally to 2,726,803.

What to read next

WHO validates Sinovac COVID-19 vaccine for emergency use
Delaying second Pfizer vaccines to 12 weeks significantly increases antibody responses in older people
New vaccine to provide 2-year protection